Welltower (Affiliate) to Acquire NorthStar Healthcare Income; TPG to Acquire Altus Power; Jade Biosciences to Merge with Aerovate Therapeutics (Plus KVAC/ Madera SPAC Merger)
March 18, 2025
The announcement flags multiple pending M&A actions in which NorthStar Healthcare Income is proposed to be acquired by an affiliate of Welltower for $3.03 per share in cash, Altus Power is proposed to be acquired by TPG for $5.00 per share in an all-cash deal, and Aerovate Therapeutics is proposed to merge with Jade Biosciences. It also references Keen Vision Acquisition Corp. in connection with a proposed merger with Madera Inc.
- Buyers
- Welltower Inc. (via affiliate), TPG, Jade Biosciences, Inc., Keen Vision Acquisition Corp.
- Targets
- NorthStar Healthcare Income, Inc., Altus Power, Inc., Aerovate Therapeutics, Inc., Keen Vision Acquisition Corp., Madera Inc.
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Aerovate Therapeutics to Merge with Jade Biosciences
April 7, 2025
Biotechnology
Aerovate Therapeutics announced it expects to declare a cash dividend to its pre-merger stockholders in connection with its previously announced merger with Jade Biosciences. The cash dividend is expected to total $67.6 million to $69.6 million, with the closing expected no later than April 30, 2025 and subject to stockholder approvals and customary closing conditions.
-
Keen Vision Acquisition Corporation to Merge with Medera Inc. (NASDAQ Listing)
September 5, 2024
Biotechnology
Keen Vision Acquisition Corporation (KVAC) entered into a definitive merger agreement with clinical-stage biotechnology company Medera Inc. to take Medera public on Nasdaq, expected to close in the fourth quarter of 2024. The business combination is expected to provide funds that will accelerate Medera’s three most advanced AAV-based gene therapy programs.
-
TPG Acquires Altus Power for $2.2 Billion
February 6, 2025
Infrastructure
Altus Power, a commercial-scale clean energy provider focused on solar and related infrastructure, agreed to be acquired by TPG through its TPG Rise Climate Transition Infrastructure strategy in an all-cash deal valued at about $2.2 billion (including outstanding debt). In the merger, Altus Power stockholders receive $5.00 per share. The transaction closed in April 2025 and Altus Power became privately held, with its NYSE listing removed.
-
Merz Lifecare Acquires Majority Stake in WindStar Medical from Oakley Capital
October 7, 2024
Consumer Products
Oakley Capital Fund IV has agreed to combine its portfolio company WindStar Medical with Merz Lifecare, with the Merz Group taking a majority stake in the new holding. The transaction — subject to regulatory approvals — will create a leading provider of OTC health, wellbeing and beauty products in the DACH region and continues Oakley’s support of WindStar following its 2020 investment.
-
TPG Capital and Leonard Green & Partners Invest in WellSky
July 20, 2020
Healthcare Services
WellSky has agreed to a new capital partnership that adds Leonard Green & Partners alongside existing investor TPG Capital, with TPG making a new equity investment and creating a new capital structure for the company. The recapitalization is intended to accelerate WellSky's technology innovation and expansion across the post-acute and community care continuum; terms were not disclosed and the deal was expected to close in Q3 2020.
-
WellSky Acquires Corridor from HealthEdge Investment Partners
October 12, 2023
Healthcare Services
WellSky, a health and community care technology company backed by Leonard Green and TPG, has acquired The Corridor Group Holdings (Corridor) from HealthEdge Investment Partners. The acquisition expands WellSky's medical coding and revenue cycle management (RCM) capabilities for the post-acute care market and brings Corridor's tech-enabled coding, clinical documentation review, billing and collections services into WellSky's platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.